Australia’s trusted immunisation experts
23 October 2025 | NewsPacific island countries and Japan achieve measles and rubella elimination: a milestone for regional health securityRead the full article
NCIRS leads a range of vaccine safety activities in partnership with the Therapeutic Goods Administration (TGA). These ensure that adverse events following immunisation (AEFI) are effectively monitored, assessed and managed.
AusVaxSafety is Australia’s national active vaccine safety surveillance system and has been operating for over a decade. It uses online surveys to collect data directly from people after vaccination, providing real-time safety monitoring for all new immunisation programs and ongoing surveillance of existing vaccines.
Learn more about AusVaxSafety
The Adverse Events Following Immunisation Clinical Assessment Network (AEFI-CAN) is a national network with more than 60 members, including:
AEFI-CAN works collaboratively to:
NCIRS provides a wide range of vaccine safety resources and education to support healthcare professionals, public health units and government stakeholders. These include evidence-based online materials focused on vaccine safety and adverse event management, alongside regularly scheduled webinars and workshops that address current and emerging safety topics.
For more than 20 years, NCIRS has worked in close partnership with the TGA to produce annual vaccine safety reports based on data from the Adverse Event Monitoring System (AEMS). This collaboration has evolved to integrate data from both active and passive surveillance systems, enhancing regulatory decision-making and improving public communication on vaccine safety.